日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Genetically humanized phenylketonuria mouse model as a testing tool for human genome editing in fertilized eggs

基因人源化苯丙酮尿症小鼠模型作为受精卵中人类基因组编辑的测试工具

期刊:Journal of Inherited Metabolic Disease
影响因子:4.2
doi:10.1002/jimd.12803
Atsumi Tsuji-Hosokawa, Iku Tsuchiya, Kie Shimizu, Miho Terao, Mito Yasuhara, Natsuho Miyamoto, Saki Kikuchi, Yuya Ogawa, Kazuaki Nakamura, Yoichi Matsubara, Shuji Takada
发表日期：2025
文献求助 收藏

Internet survey on EpiPen adrenaline autoinjector usage in Japanese patients with a history of anaphylaxis

一项关于日本有过敏史患者使用EpiPen肾上腺素自动注射器的网络调查

期刊:Asia Pacific Allergy
影响因子:2.1
doi:10.5415/apallergy.0000000000000209
Nakamura, Yoichi; Hashiba, Yoko; Furuie, Masashi; Okayasu, Kaori; Isozaki, Atsushi; Hasebe, Yuko; Kaburaki, Mariko
免疫/内分泌
发表日期：2025
文献求助 收藏

Psychological and motivational factors associated with addiction tendencies to gaming, video viewing, and social networking services use among high school students: A cross-sectional study

高中生游戏、视频观看和社交网络服务成瘾倾向的心理和动机因素：一项横断面研究

期刊:PCN Reports
影响因子:0.9
doi:10.1002/pcn5.70218
Inaguma, Tokuya; Funatogawa, Tomoyuki; Sekizaki, Ryo; Nakamura, Yoichi; Mizuno, Masafumi; Nemoto, Takahiro
发表日期：2025
文献求助 收藏

Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321

一项随机、II期研究，比较在接受顺铂、培美曲塞和贝伐单抗治疗后，培美曲塞联合贝伐单抗与单用培美曲塞治疗晚期非鳞状非小细胞肺癌的疗效：TORG（胸部肿瘤研究组）1321

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.6135
Kasai, Takashi; Mori, Kiyoshi; Nakamura, Yoichi; Seki, Nobuhiko; Ichikawa, Yasuko; Saito, Haruhiro; Kondo, Tetsuro; Nishikawa, Kazuo; Otsu, Satoshi; Bessho, Akihiro; Tanaka, Hiroshi; Yamaguchi, Hiroyuki; Kaburagi, Takayuki; Imai, Hisao; Mori, Keita; Ohtake, Junya; Okamoto, Hiroaki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study

奥希替尼作为EGFR突变阳性晚期非小细胞肺癌老年患者一线治疗的II期临床试验：SPIRAL-0研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyac193
Chihara, Yusuke; Takeda, Takayuki; Goto, Yasuhiro; Nakamura, Yoichi; Tsuchiya-Kawano, Yuko; Nakao, Akira; Onoi, Keisuke; Hibino, Makoto; Fukuda, Minoru; Honda, Ryoichi; Yamada, Takahiro; Taniguchi, Ryusuke; Sakamoto, Sinjiro; Date, Koji; Nagashima, Seiji; Tanzawa, Shigeru; Minato, Koichi; Nakatani, Koichi; Izumi, Miiru; Shimose, Takayuki; Kishimoto, Junji; Uchino, Junji; Takayama, Koichi
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2022
文献求助 收藏

Effects of luseogliflozin on estimated plasma volume in patients with heart failure with preserved ejection fraction

卢格列净对射血分数保留型心力衰竭患者估计血浆容量的影响

期刊:Esc Heart Failure
影响因子:3.7
doi:10.1002/ehf2.13683
Nakashima, Mitsutaka; Miyoshi, Toru; Ejiri, Kentaro; Kihara, Hajime; Hata, Yoshiki; Nagano, Toshihiko; Takaishi, Atsushi; Toda, Hironobu; Nanba, Seiji; Nakamura, Yoichi; Akagi, Satoshi; Sakuragi, Satoru; Minagawa, Taro; Kawai, Yusuke; Nishii, Nobuhiro; Fuke, Soichiro; Yoshikawa, Masaki; Nakamura, Kazufumi; Ito, Hiroshi
心力衰竭
心血管
发表日期：2022
文献求助 收藏

Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study

阿姆鲁比星单药治疗复发性小细胞肺癌患者的临床疗效：一项多中心回顾性研究

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-22-160
Uda, Sayaka; Yamada, Tadaaki; Yoshimura, Akihiro; Goto, Yasuhiro; Yoshimine, Kohei; Nakamura, Yoichi; Shiotsu, Shinsuke; Yokoi, Takashi; Tamiya, Nobuyo; Kimura, Hideharu; Chihara, Yusuke; Umeda, Yukihiro; Izumi, Miiru; Takeda, Takayuki; Yamada, Takahiro; Hibino, Makoto; Hiranuma, Osamu; Ito, Kazuhiro; Okada, Asuka; Osugi, Shuji; Takemura, Yoshizumi; Ishii, Hiroshi; Chibana, Kenji; Hasegawa, Isao; Morimoto, Yoshie; Iwasaku, Masahiro; Tokuda, Shinsaku; Takayama, Koichi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Trial

奥希替尼联合贝伐珠单抗治疗未经治疗的EGFR突变型非小细胞肺癌合并恶性胸膜或心包积液（SPIRAL II）：一项单臂、开放标签的II期临床试验

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100424
Hibino, Makoto; Hiranuma, Osamu; Takemura, Yoshizumi; Katayama, Yuki; Chihara, Yusuke; Harada, Taishi; Fujita, Kohei; Kita, Toshiyuki; Tamiya, Nobuyo; Tsuda, Takeshi; Shiotsu, Shinsuke; Tamura, Yukihiro; Aoyama, Takashi; Nakamura, Yoichi; Terashima, Masaaki; Morimoto, Yoshie; Nagata, Kazuhiro; Yoshimura, Kenichi; Uchino, Junji; Takayama, Koichi
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2022
文献求助 收藏

Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer

一项随机II期临床试验，比较S-1联合顺铂或多西他赛联合顺铂，同时进行胸部放疗治疗不可手术的III期非小细胞肺癌的疗效。

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3641
Shimokawa, Tsuneo; Yamada, Kazuhiko; Tanaka, Hiroshi; Kubota, Kaoru; Takiguchi, Yuichi; Kishi, Kazuma; Saito, Haruhiro; Hosomi, Yukio; Kato, Terufumi; Harada, Daijiro; Otani, Sakiko; Kasai, Takashi; Nakamura, Yoichi; Misumi, Toshihiro; Yamanaka, Takeharu; Okamoto, Hiroaki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus

卢格列净对糖尿病合并射血分数保留型心力衰竭患者的影响

期刊:Journal of the American Heart Association
影响因子:5.3
doi:10.1161/JAHA.119.015103
Ejiri, Kentaro; Miyoshi, Toru; Kihara, Hajime; Hata, Yoshiki; Nagano, Toshihiko; Takaishi, Atsushi; Toda, Hironobu; Nanba, Seiji; Nakamura, Yoichi; Akagi, Satoshi; Sakuragi, Satoru; Minagawa, Taro; Kawai, Yusuke; Nishii, Nobuhiro; Fuke, Soichiro; Yoshikawa, Masaki; Nakamura, Kazufumi; Ito, Hiroshi
糖尿病
心力衰竭
心血管
代谢
发表日期：2020
文献求助 收藏